Valuation : Aptamer Group PLC

Market Cap 1.73Cr 2.34Cr 2.01Cr 1.91Cr 3.24Cr 223.2Cr 3.26Cr 23Cr 8.7Cr 113.55Cr 8.77Cr 8.58Cr 358.81Cr P/E 2024
-0.91x
P/E 2025 -2.93x
Enterprise Value 1.67Cr 2.26Cr 1.95Cr 1.84Cr 3.13Cr 215.86Cr 3.15Cr 22Cr 8.42Cr 109.82Cr 8.49Cr 8.3Cr 347.02Cr EV / Sales 2024
3.47x
EV / Sales 2025 6.31x
Free-Float
75.45%
Yield 2024 *
-
Yield 2025 -
Current month+15.38%
1 month-6.48%
3 months-28.57%
6 months-55.88%
Current year-65.12%
1 week 0.35
Extreme 0.35
0.4
1 month 0.3
Extreme 0.3
0.45
Current year 0.3
Extreme 0.3
1.15
1 year 0.3
Extreme 0.3
1.25
3 years 0.2
Extreme 0.2
1.59
5 years 0.2
Extreme 0.2
157
10 years 0.2
Extreme 0.2
157
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 01/01/2008
Chief Executive Officer 48 14/08/2024
Director of Finance/CFO - 01/01/2022
Director TitleAgeSince
Director/Board Member 48 01/01/2008
Director/Board Member - 29/05/2014
Chairman 48 14/08/2024
Date Insider Type Main position Quantity % Market Cap. Importance
09/09/25 Buy

Chairman

50,00,000 0.1879%
18/07/25 Free

Director

29,68,695 0.1491%
28/01/25 Free

Director

34,99,343 0.1760%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-65.91%-71.70% 1.75Cr
+0.54%-4.61%-5.08%+21.63% 4.25TCr
-1.51%-5.52%-44.93%+127.19% 1.23TCr
-0.28%-1.52%-10.90%+75.78% 568.69Cr
+9.65%+1.98%+49.43% - 433.72Cr
+2.14%-4.09% - - 201.77Cr
+1.67%-4.60%+3.02%-38.62% 149.57Cr
+0.89%-4.85%-36.83% - 104.27Cr
0.00%-0.58%+14.80%+152.22% 101.3Cr
-2.09%-5.21%+34.13%+37.70% 88Cr
Average +1.10%-2.72%-6.92%+43.46% 712.93Cr
Weighted average by Cap. +0.71%-4.04%-8.75%+47.65%

Financials

2024 2025
Net sales 9L 11.63L 10.02L 9L 16.13L 11Cr 16.22L 1.13Cr 43.33L 5.65Cr 43.68L 42.72L 18Cr 12.03L 16.27L 14.02L 13.27L 22.57L 16Cr 22.68L 1.58Cr 60.62L 7.91Cr 61.1L 59.76L 25Cr
Net income -29.58L -40L -34.47L -32.63L -55.49L -38Cr -55.78L -3.88Cr -1.49Cr -19Cr -1.5Cr -1.47Cr -61Cr -24.24L -32.78L -28.24L -26.74L -45.48L -31Cr -45.71L -3.18Cr -1.22Cr -16Cr -1.23Cr -1.2Cr -50Cr
Net Debt -53T -71.67T -61.75T -58.47T -99.43T -68.47L -99.93T -7L -3L -34.84L -3L -3L -1.1Cr -6L -8L -7L -6L -10.66L -7.34Cr -10.71L -74.43L -28.62L -3.73Cr -28.85L -28.21L -12Cr
Logo Aptamer Group PLC
Aptamer Group plc is a United Kingdom-based global developer of aptamer-based ligands. The Company develops custom affinity binders through its Optimer platform to enable new approaches in therapeutics, diagnostics and research applications. The Company's Optimer platform delivers aptamer tools that are enabling researchers and developers across the spectrum of the life sciences. Its Optimer binders have been developed for a range of applications, including therapeutic inhibitors and modulators, drug delivery vehicles, protein purification and separation, biomarker screening and validation, in vitro research, quality control analysis, pharmacokinetic and drug assays, and in vitro diagnostic assays. Its Aptamer Diagnostics division uses the Company's technology to support the development of diagnostic platforms, such as proteomics, lateral flow devices, biosensors and immunoassays, such as enzyme-linked immunosorbent assay (ELISA).
Employees
30
Date Price Change Volume
11/26/11 GBX 0.3750 0.00% 1,07,39,410
10/26/10 GBX 0.3750 0.00% 20,85,994
09/26/09 GBX 0.3750 0.00% 45,76,134
08/26/08 GBX 0.3750 0.00% 49,29,684
07/26/07 GBX 0.3750 0.00% 2,34,82,058

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APTA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!